查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1918107

流式细胞技术市场－2026-2031年预测

Flow Cytometry Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计流式细胞技术市场将从 2025 年的 61.96 亿美元成长到 2031 年的 94.79 亿美元，复合年增长率为 7.34%。

由于流式细胞技术市场正经历显着扩张。该技术能够快速分析单一细胞的物理和化学特性，使其成为从免疫表型分析到细胞分级分离等多种应用的必备工具。市场成长的驱动因素包括某些疾病盛行率的上升、技术的不断进步以及政府机构和研究机构的大力支持。

流式细胞技术广泛而多样的应用是市场成长的关键驱动因素。此技术可用于分析多种检体，包括骨髓、全血和固态组织。其功能涵盖免疫表型分析、利用萤光染料进行DNA/RNA含量分析、异质细胞群的特性。这种多功能性确保了其作为医学领域诊断和后续观察白血病、淋巴瘤和自体免疫疾病等疾病的基础工具以及生命科学研究的关键手段，拥有持续的需求。

某些疾病日益加重的全球负担是推动市场扩张的主要因素。流式细胞技术在爱滋病毒的防治和研究中发挥关键作用，它常与聚合酶炼式反应（PCR）联用，用于病毒分型和定量。同样，其在肿瘤学领域用于癌症分类和监测的应用也持续推动市场需求。此外，该技术对于诊断和研究影响全球数百万人的多种原发性和续发性免疫力缺乏至关重要，这些疾病通常需要先进的细胞分析技术才能进行适当的特性分析和治疗。

大规模研究倡议和政府资助正在加速市场发展。旨在降低爱滋病毒感染率的公共卫生目标以及对干细胞和再生医学研究的大量津贴，为先进分析技术的应用创造了有利环境。这些措施通常直接资助流式细胞技术的基础设施和耗材。同时，技术创新，特别是样品製备和系统操作自动化的趋势，正在推动效率的提高、工作流程的标准化和可重复性的增强。这种发展使得该技术在更广泛的实验室环境中更易于使用且更可靠。

该市场为成熟企业和新参与企业都提供了巨大的机会。持续的技术进步，以及政府支持的旨在促进技术应用和提供生物製造领域专业培训的项目，正在降低准入门槛。这些发展使得新参与企业能够透过专注于满足日益增长的标准化、合规分析工具需求的专业应用、服务或创新产品特性来进入市场。

从区域来看，北美预计将实现显着成长并保持其领先的市场份额。这一主导地位归功于该地区爱滋病和癌症等重大疾病的高发生率、强大且技术先进的医疗保健基础设施以及巨额的医疗保健支出。主要市场参与者的存在和浓厚的生物医学研究氛围进一步巩固了该地区的领先地位，推动了流式细胞技术在诊断中心和研究实验室中的应用。

竞争格局既包括Apogee Flow Systems等专业公司，也包括Bio-Rad Laboratories和Sysmex Corporation等多元化的全球领导者。这些公司致力于开发综合解决方案，产品范围涵盖高效能的特定应用型细胞仪，以及专为临床诊断环境设计的全自动整合系统。一个关键的行业趋势是越来越多地利用软体功能来确保资料完整性并符合生产规范。这反映了市场的成熟度以及受法规环境下对可靠、标准化数据日益增长的需求。

本报告的主要优势：

  • 深入分析：取得以客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他细分市场为重点的深入市场洞察，涵盖主要地区和新兴地区。
  • 竞争格局：了解主要企业采取的策略倡议，并了解透过正确的策略打入市场的潜力。
  • 市场驱动因素与未来趋势：探索动态因素和关键市场趋势，以及它们将如何塑造未来的市场发展。
  • 可执行的建议：利用洞察力为策略决策提供讯息，从而在动态环境中开拓新的业务管道和收入来源。
  • 受众范围广：对新兴企业、研究机构、顾问公司、中小企业和大型企业都有益处且经济高效。

它是用来做什么的？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及影响、新产品开发、竞争影响

分析范围

  • 历史资料（2021-2025 年）和预测资料（2026-2031 年）
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按业务板块和地区（国家）分類的收入成长和预测分析
  • 公司概况（策略、产品、财务资讯、关键趋势等）

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 分析范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策和法规
  • 策略建议

第四章 技术展望

第五章 依产品类型流式细胞技术市场

  • 介绍
  • 装置
  • 试剂

第六章 依技术分類的流式细胞技术市场

  • 介绍
  • 雷射基座
  • 电阻法

第七章流式细胞技术市场依应用领域划分

  • 介绍
  • 分子生物学
  • 病理
  • 免疫学
  • 其他的

第八章 依最终用户分類的流式细胞技术市场

  • 介绍
  • 医院和诊所
  • 学术和研究机构
  • 其他的

第九章流式细胞技术市场（按地区划分）

  • 介绍
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 台湾
    • 其他的

第十章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 企业合併、协议、商业合作
  • 竞争对手仪錶板

第十一章：公司简介

  • Danaher Corporation
  • Becton Dickinson and Company
  • Sysmex Corp.
  • Agilent Technologies, Inc.
  • Apogee Flow Systems Ltd.
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.
  • Stratedigm, Inc.
  • Miltenyi Biotec
  • Diasorin

第十二章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 分析方法
  • 简称
简介目录
Product Code: KSI061615577

The flow cytometry market, at a 7.34% CAGR, is projected to increase from USD 6.196 billion in 2025 to USD 9.479 billion in 2031.

The flow cytometry market is experiencing significant expansion, driven by its critical role in both clinical diagnostics and advanced research. This technology, which enables the rapid analysis of single cells to measure physical and chemical characteristics, has become indispensable for applications ranging from immunophenotyping to cell sorting. The market's growth is propelled by the increasing prevalence of specific diseases, continuous technological advancements, and substantial support from governmental and research institutions.

A primary driver of market growth is the extensive and diverse application portfolio of flow cytometry. The technology is utilized for analyzing a wide variety of specimens, including bone marrow, whole blood, and solid tissues. Its capabilities extend to immunophenotyping, DNA/RNA content analysis via fluorescent dyes, and the characterization of heterogeneous cell populations. This versatility makes it a cornerstone tool in healthcare for diagnosing and monitoring conditions such as leukemia, lymphoma, and autoimmune disorders, as well as a vital instrument in life sciences research, thereby ensuring sustained demand.

The rising global burden of specific diseases is a major factor bolstering market expansion. Flow cytometry plays an essential role in the management and study of HIV, where it is used in conjunction with PCR for viral subtyping and quantification. Similarly, its application in oncology for cancer classification and monitoring continues to be a significant demand driver. Furthermore, the technology is crucial for diagnosing and researching a wide spectrum of primary and secondary immunodeficiency disorders, conditions that affect millions worldwide and often require sophisticated cellular analysis for proper characterization and management.

Substantial research initiatives and government funding are accelerating market development. Public health goals aimed at reducing HIV incidence and significant grants for stem cell and regenerative medicine research create a favorable environment for the adoption of advanced analytical technologies. These initiatives often directly fund the infrastructure and consumables that drive flow cytometry usage. Concurrently, technological innovation, particularly the trend toward automation in sample preparation and system operation, is enhancing efficiency, standardizing workflows, and improving reproducibility. This evolution makes the technology more accessible and reliable for a broader range of laboratory settings.

The market presents considerable opportunities for both established players and new entrants. Ongoing technological advancements, coupled with government-backed programs that encourage technology adoption in biomanufacturing and provide specialized training, are lowering barriers to entry. These developments enable new participants to enter the market with a focus on specialized applications, services, or innovative product features that address the growing demand for standardized and compliant analytical tools.

Geographically, North America is expected to witness notable growth and maintain a significant market share. This leadership is attributed to the region's higher prevalence of key diseases such as HIV and cancer, a robust and technologically advanced healthcare infrastructure, and substantial healthcare expenditure. The presence of leading market players and a strong culture of biomedical research further consolidate the region's dominant position, driving the adoption of flow cytometry in both diagnostic centers and research institutions.

The competitive landscape includes specialized firms such as Apogee Flow Systems and diversified global leaders like Bio-Rad Laboratories and Sysmex Corp. These companies are focused on developing comprehensive solutions that range from high-performance cytometers for specific applications to fully automated, integrated systems designed for clinical diagnostic environments. A key industry trend is the enhancement of software capabilities to ensure data integrity and compliance with manufacturing guidelines, reflecting the market's maturation and the increasing need for reliable, standardized data in regulated environments.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Flow Cytometry Market Segmentation:

  • By Product Type
  • Instruments
  • Reagents
  • By Technology
  • Laser-Based
  • Impedance-Based
  • By Application
  • Molecular Biology
  • Pathology
  • Immunology
  • Others
  • By End-User
  • Hospitals & Clinics
  • Academic & Research Institutes
  • Others
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. FLOW CYTOMETRY MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Instruments
  • 5.3. Reagents

6. FLOW CYTOMETRY MARKET BY TECHNOLOGY

  • 6.1. Introduction
  • 6.2. Laser-Based
  • 6.3. Impedance-Based

7. FLOW CYTOMETRY MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Molecular Biology
  • 7.3. Pathlogy
  • 7.4. Immunology
  • 7.5. Others

8. FLOW CYTOMETRY MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Hospitals & Clinics
  • 8.3. Academic & Research Institutes
  • 8.4. Others

9. FLOW CYTOMETRY MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. United Kingdom
    • 9.4.4. Spain
    • 9.4.5. Italy
    • 9.4.6. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Israel
    • 9.5.4. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. South Korea
    • 9.6.5. Indonesia
    • 9.6.6. Thailand
    • 9.6.7. Taiwan
    • 9.6.8. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Danaher Corporation
  • 11.2. Becton Dickinson and Company
  • 11.3. Sysmex Corp.
  • 11.4. Agilent Technologies, Inc.
  • 11.5. Apogee Flow Systems Ltd.
  • 11.6. Bio-Rad Laboratories, Inc.
  • 11.7. Thermo Fisher Scientific, Inc.
  • 11.8. Stratedigm, Inc.
  • 11.9. Miltenyi Biotec
  • 11.10. Diasorin

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key Benefits for the Stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations